Filtered By:
Vaccination: Cervical Cancer Vaccine

This page shows you your search results in order of relevance. This is page number 2.

Order by Relevance | Date

Total 852 results found since Jan 2013.

Promiscuity and the HPV Vaccine: Any Link?Promiscuity and the HPV Vaccine: Any Link?
Sandra Fryhofer covers the evidence concerning the human papillomavirus vaccine and concerns about increased promiscuity in teenagers. Medscape Internal Medicine
Source: Medscape Today Headlines - April 19, 2013 Category: Consumer Health News Tags: Internal Medicine Commentary Source Type: news

Physicians slow to implement HPV vaccination and cervical cancer screening guidelines
(Elsevier Health Sciences) Recent breakthroughs in cervical cancer prevention have resulted in new vaccination and cervical cancer screening guidelines. Recommendations do not always translate into practice, however. Less than one-third of obstetrician-gynecologists vaccinate their eligible patients against the human papilloma virus, and only half adhere to cervical cancer prevention guidelines published three years previously, according to a survey published this month in the American Journal of Preventive Medicine.
Source: EurekAlert! - Medicine and Health - July 9, 2013 Category: Global & Universal Source Type: news

Are two doses of the HPV vaccine as effective as three?
The human papillomavirus vaccine was introduced in 2006 as a three-step vaccine series that significantly drops the risk of contracting HPV and developing cervical cancer in young women. Since the introduction of the vaccine, 100 million doses have been administered, with a 50 percent drop in the HPV rate among teenage girls. According to Jessica Kahn, M.D., MPH, the vaccine has been proven to be ....
Source: Sound Medicine - July 20, 2013 Category: Global & Universal Authors: Sound Medicine Source Type: news

Physicians’ Human Papillomavirus Vaccine Recommendations, 2009 and 2011
Conclusions: Results suggest a modest increase in recommendations for HPV vaccination of girls aged 11 or 12 years over a 2-year period; however, recommendations remain suboptimal for all age groups despite national recommendations for universal immunization.
Source: American Journal of Preventive Medicine - December 20, 2013 Category: Global & Universal Authors: Susan T. Vadaparampil, Teri L. Malo, Jessica A. Kahn, Daniel A. Salmon, Ji-Hyun Lee, Gwendolyn P. Quinn, Richard G. Roetzheim, Karen L. Bruder, Tina M. Proveaux, Xiuhua Zhao, Neal A. Halsey, Anna R. Giuliano Tags: Brief Reports Source Type: research

Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission
Nature Medicine 20, 296 (2014). doi:10.1038/nm.3471 Authors: Alejandro B Balazs, Yong Ouyang, Christin M Hong, Joyce Chen, Steven M Nguyen, Dinesh S Rao, Dong Sung An & David Baltimore The vast majority of new HIV infections result from relatively inefficient transmission of the virus across mucosal surfaces during sexual intercourse. A consequence of this inefficiency is that small numbers of transmitted founder viruses initiate most heterosexual infections. This natural bottleneck to transmission has stimulated efforts to develop interventions that are aimed at blocking this step of the infection process. Des...
Source: Nature Medicine - February 9, 2014 Category: Journals (General) Authors: Alejandro B BalazsYong OuyangChristin M HongJoyce ChenSteven M NguyenDinesh S RaoDong Sung AnDavid Baltimore Tags: Letter Source Type: research

A new way to screen for cervical cancer
In April, the FDA approved the use of a new human papillomavirus test for primary cervical cancer screening. Aaron Ermel, M.D., discusses the newly approved test, the reasons it should not be used in women under 25 and the impact this test will have on cervical cancer screenings in the future. Sydney Spiesel, M.D., Ph.D., joins Dr. Ermel to discuss why parents may be reluctant to vaccinate the....
Source: Sound Medicine - June 1, 2014 Category: Global & Universal Authors: Sound Medicine Source Type: news

Beliefs, behaviors and HPV vaccine: Correcting the myths and the misinformation
Conclusion Most fears related to HPV vaccine are more related to myth than reality. In the absence of major health policy initiatives, such as those implemented in Canada, the U.K., and Australia, a multi-level, multi-faceted approach will be required to achieve high rates of HPV vaccination. It will be essential to focus on the education of HCPs regarding indications for HPV vaccination and approaches to communicating most effectively with parents and patients about the safety and benefits of vaccination and the risks associated with non-vaccination.
Source: Preventive Medicine - November 10, 2014 Category: Global & Universal Source Type: research

A community-based intervention in middle schools to improve HPV vaccination and cervical cancer screening in Japan
AimJapan has low rates of cervical cancer screening and Human papilloma virus (HPV) vaccination. This research examines the effectiveness of a family medicine resident-led, intervention in increasing knowledge about HPV and cervical cancer in middle school-girls and increasing knowledge and intention to have cervical cancer screening in their mothers. Methods: We utilized a pre-test/post-test intervention design in three rural middle schools with 7th grade middle school-girls and their mothers. A school-based activity educated girls about HPV and cervical cancer. A home-based activity utilized a homework assignment for gir...
Source: Asia Pacific Family Medicine - November 18, 2014 Category: Primary Care Authors: Tomoko ItoRemi TakenoshitaKeiichiro NarumotoMelissa PlegueAnanda SenBenjamin CrabtreeMichael Fetters Source Type: research

Adult Vaccination Disparities Among Foreign-Born Populations in the U.S., 2012
Conclusions Vaccination coverage is lower among foreign-born adults than those born in the U.S. It is important to consider foreign birth and immigration status when assessing vaccination disparities and planning interventions.
Source: American Journal of Preventive Medicine - November 19, 2014 Category: Global & Universal Source Type: research

Effect of Decision Support on Missed Opportunities for Human Papillomavirus Vaccination
Conclusions Clinician-focused decision support is a more effective strategy than family-focused to prevent missed HPV vaccination opportunities. Given the persistence of missed opportunities even in intervention groups, complementary strategies are needed. This study is registered at clinicaltrials.gov NCT01159093.
Source: American Journal of Preventive Medicine - November 19, 2014 Category: Global & Universal Source Type: research

Study finds provider-focused intervention improves HPV vaccination rates
(Boston University Medical Center) Changing the way doctors practice medicine is difficult, however a new study has shown that combining traditional education with quality improvement and incentives improves Human Papilloma virus vaccination rates in boys and girls. The study, which appears on-line in the journal Vaccine, has the potential to produce sustained improvements in these vaccination rates.
Source: EurekAlert! - Medicine and Health - November 24, 2014 Category: Global & Universal Source Type: news

Predictors of Human Papillomavirus Awareness and Knowledge in 2013 Gaps and Opportunities for Targeted Communication Strategies
Conclusions Although awareness and knowledge of HPV is increasing, there are opportunities to target communication with populations for whom knowledge gaps currently exist, in order to promote dialogue about the vaccine among patients and their providers.
Source: American Journal of Preventive Medicine - February 28, 2015 Category: Global & Universal Source Type: research

Impact of Health Insurance Status on Vaccination Coverage Among Adult Populations
Conclusions Overall, vaccination coverage among adults aged ≥18 years is lower among uninsured populations. Implementation of effective strategies is needed to help improve vaccination coverage among adults aged ≥18 years, especially those without health insurance.
Source: American Journal of Preventive Medicine - April 29, 2015 Category: Global & Universal Source Type: research

Autoimmune/auto-inflammatory syndrome induced by adjuvants (ASIA) after quadrivalent human papillomavirus vaccination in Colombians: a call for personalised medicine.
Authors: Anaya JM, Reyes B, Perdomo-Arciniegas AM, Camacho-Rodríguez B, Rojas-Villarraga A Abstract This was a case study in which 3 patients with autoimmune/auto-inflammatory syndrome induced by adjuvants (ASIA) after quadrivalent human papillomavirus vaccination (HPV) were evaluated and described. All the patients were women. Diagnosis consisted of HLA-B27 enthesitis related arthritis, rheumatoid arthritis and systemic lupus erythematous, respectively. Our results highlight the risk of developing ASIA after HPV vaccination and may serve to increase the awareness of such a complication. Factors that are predictiv...
Source: Clinical and Experimental Rheumatology - May 13, 2015 Category: Rheumatology Tags: Clin Exp Rheumatol Source Type: research

Interstitial lung disease associated with human papillomavirus vaccination
We report a case of ILD associated with a Cervarix vaccination. A woman in her 40’s, with a history of conisation, received three inoculations of Cervarix. Three months later, she presented with a cough and shortness of breath. Findings from a computed tomography of the chest and a transbronchial lung biopsy were consistent with non-specific interstitial pneumonia. Workup eliminated all other causes of the ILD, except for the vaccination. Over the 11 months of the follow-up period, her symptoms resolved without steroid therapy. The onset and spontaneous resolution of the ILD showed a chronological association with the HP...
Source: Respiratory Medicine Case Reports - June 12, 2015 Category: Respiratory Medicine Source Type: research